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1. Introduction 
The classical complement .re.action is known to be 
triggered by activation of C1, which is a Ca2+-depend - 
ent complex of Clq, Clr and Cls subunits [1]. Clq 
is a collagen-like protein having a binding site for imm- 
une complexes [2,3]. Clr and Cls are zymogens from 
which tryspin-like proteases, C l i  and C 1 if, are activ- 
ated, respectively [4]. The activation of Clr is a key 
reaction for initiation of the classical complement 
reaction, since the active form, Clt-, is an intrinsic 
activator for Cls [5], and the activated Clff, in turn, 
attacks C4 and C2 to initiate immune reactions [6]. 
Recently, the activation of Cls by Cl fhas been 
shown to be a proteolytic process [7,9], as is the case 
of activation of other plasma zymogens in blood clot- 
ting and fibrinolysis ystems [10]. However, extra- 
ordinary instability of C 1 r and C 1 r has made their 
purifications extremely difficult and, therefore, little 
is known on the molecular change accompanying the 
conversion, of Clr into CI?. 
In previous papers, we reported simple methods 
for isolation of Cl~-Clgcomplex [11] and Cl-s [9] 
Abbreviations, The symbols for complement components 
used in this paper conform to the recommendations of the 
World Health Organization Committee on Complement 
Nomenclature; lmmunochemistry, (1970) 7,137-142. 
Activated components were indicated by placing a bar 
over the numeral which refers to the active component or
subunit. Other abbreviations u ed are: CPD, citrate- 
phosphate dextrose; AAME, N-a-acetyl - L - arginine 
methylester; AGLME, acetylglycyl - L- lysine methylester; 
ATEE, N-a-acetyl-L-tyrosine ethylester; DFP, diisopro- 
pylfluorophosphate; SDS, sodium dodecylsulfate; EDTA, 
ethylenediamine tetraacetate. 
from human plasma, using polyethylene glycol fract- 
ionation and affinity chromatography with IgG-Seph- 
arose. In the present study, a simple method has been 
designed for isolation of CI~ from human .plasma nd 
some polypeptide chain structure of Cl-r has been 
investigated. 
It will be shown that the polypeptide chain struct- 
ure of C1) is very similar to that of CI~; C1) also con- 
sists of two chains, heavy and light chains, connected 
covalently by a disulfide bridge and the DFP-reactive 
active site of CI{ locates on the light chain portion, 
which has lie as its NH2 -terminal amino acid. 
Based on the similarity of gross structure of CI? 
to that of CI~, it is proposed that the activation of 
CI~ should also involve some proteolytic process, 
such as is observed with the activation of Cls. 
2. Experimental 
CDP-human plasma was obtained from the Blood 
Bank of the Japanese Red Cross, Hokkaido, Japan. De- 
fibrinated Clfraction was prepared with polyethylene 
glycol (#4000) from human plasma as described in a 
previous paper [11 ]. IgG-Sepharose 6B was prepar- 
ed according to the modified method of Assimah 
et al. [12]. CI~ activity was determined by its abil- 
ity to hydrolyze synthetic amino acid ester or to con- 
vert Cls into Clg as described in a previous paper [11]. 
The esterase activity of Clg thus activated by CI? 
was determined with AGLME as the substrate by the 
hydroxamate method [13]. Cls used was purified by 
a slight modification [9] of the method of Sakai and 
Stroud [7] from human plasma. 
Polyacrylamide gel electrophoresis was performed 
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in the presence or absence of SDS, according to the 
methods of Weber and Osborn [14] and Davis [15], 
respectively. The molecular weights of polypeptide 
chains were estimated from their electrophoretic 
mobilities on SDS-gel with bovine serum albumin 
(monomer, dimer and trimer, Sigma Chemical Co., 
USA) and soybean trypsin inhibitor (Sigma Chem- 
ical Co., USA) as standard proteins of known mol- 
ecular weight. 
Preparation and NH2-terminal determination of
two polypeptide chains of CI? were performed ess- 
entially according to the method of Weiner et al. [16]. 
Dansyl amino acids were identified by thin layer chro- 
matography with polyamide sheet (Chen Chin Co.), 
using solvent systems reported [16,!7 ). 
DFP-sensitive active site of CI~ was labelled with 
[32 p] DFP (Radiochemical Centre, Amersham, Eng- 
land) as fo!lows; about 1 mg of Cl? in 20 ml of 0.1 
M Tris-HC1 lruffer, pH 8.5 and 0.4 mCi of [32p] DFP 
(0.328 mCi/mg) in 0.4 ml of ethylene glycol were in- 
cubated at 37°C for 1 hr, dialyzed exhaustively against 
0.1 M acetic acid and lyophilized. The lyophilized 
32P-labelled Cl~was dissolved in ! ml of 0.2 M phos- 
phate buffer, pH 7.3 and electrophoresed on SDS- 
polyacrylamide g ls before and after the treatment with, 
0.1 M 2-mercaptoethanol. The gels were stained with 
Coomasie blue and sectioned into 2mm width. The 
radioactivity in sectioned gels was determined with 
a liquid scintillation counter in toluene scintillator. 
3. Results 
3.1. Purification of C1 
The various teps in purification of human CI? are 
shown in table 1. As reported in a previous paper [11], 
Ca2+-dependent C 1 F -C  1 ~ complex was isolated from 
human plasma by polyethyleneglycol fractionation 
followed by affinity chromatography on IgG-Sepha- 
rose 6B, and then chromatographed on DEAE-cellulose 
(DE-52) after the treatment with EDTA. As shown in 
fig.l, two protein peaks were eluted by increasing NaC1 
concentration; the C1 s activator activity of C 1 ? is 
associated with the first peak and ATEE esterase act- 
ivity of CI~ with the second peak. 
The CI~ fraction thus obtained gave a single band 
on polyacrylamide g l electrophoresis (fig.2a). The 
purification was about 160-fold with an overall yield 
of 36%, relative to the first precipitate with polyeth- 
ylene glycol. 
3.2. Polypeptide chains of Cl~ 
Non-reduced C1F gave a single stained band on 
SDS-polyacrylamide g l electrophoresis and its mol- 
ecular weight was estimated to be 115 000 from its 
electrophoretic mobility (fig.2b). Upon the treatment 
with 0.1 M 2-mercaptoethanol, C 1 ? dissociated into 
two components, the molecular weights of which 
were estimated to be 68 000 and 47 000, respect- 
ively (fig.2c). 
Table 1 
Purification of Clr from human plasma 
Purification step Total Total Total Specific 
volume protein activity a) activity 
(ml) (A280n m) (units) (units/A280nm) 
Plasma 300 22 000 nd 
Polyethylene glycol 
precipitate 60 840 100 0.12 
Defibrinated fraction 60 210 92 0.44 
IgG-Sepharose eluate 35 16.3 70 4.3 
DEAE-cellulose luate 60 2.00 32 19.0 
a One unit of Clf was tentatively defined at the amount of activity capable of 
activating 1 unit of Cls for 30 min. One unit of CI~ esterase is the amount of 
enzyme capable of hydrolyzing 1tzmol of AGLME per min at 37°C. The value 
was corrected for the AGLME esterase activity of C1 ~ fraction alone. 
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Fig. 1. Purification of C1 f. C1 f-C1 g complex which was ob- 
tained by affinity chromatography with IgG-Sepharose 6B 
of polyethylene glycol-precipitate of human plasma [11 ] 
was dialyzed against 0.02 M phosphate buffer, pH 7.4, con- 
taining 5mM EDTA overnight and applied to a column 
(2.0 X 4.0 cm) of DEAE-cellulose (DE-52) which had been 
equilibrated with the dialysis buffer. After washing the column 
with the phosphate buffer, the column was eluted by linear 
gradient increase of NaC1 concentration with each 200 ml 
of 0 and 0.25 M NaC1 in the phosphate buffer. Fractions 
of each 6 ml were collected at the cold room. The Clf act- 
ity was determined by measuring C1 s activator activity. 
Fractions 21-30 were pooled and used as the purified Clf. 
These results indicated that C1 ? comprises two 
polypeptide chains, connected with one or more dis- 
sulfide bridges, such as is the case of human Clg 
[7,91. 
3.3. Incorporation of [32 P] DFP into Clr 
The esterase activity of purified C1 ? was inhibited 
by incubation with DFP. As shown in fig.3, decrease 
of the esterase activity of C1 ? by DFP obeyed good 
first-order kinetics, suggesting that CI~" belongs to a 
DFposensitive serine esterase. When C1 ~ was incubat- 
ed with 32P-labelled DFP and electrophoresed on 
SDS-polyacrylamide gel, the radioactivity was found 
to be associated with the stained band of CI~ (fig.4). 
When the radioactive CI? was treated with 0.1 M 
2-mercaptoethanol and electrophoresed on SDS- 
polyacrylamide gel, the incorporated radioactivity 
was found to be associated with the stained band of 
light chain portion of CI?, indicating that the DFP- 
sensitive active site of CI~" locates on the light chain 
portion, as is the case of human CI~ [18]. 
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Fig.2. Polyacrylamide g l electrophoresis. (a) Purified C 1 f 
in 5% polyacrylamide isc gel with Tris-glycine buffer, pH 
8.6 [15]. (b) Purified Clf. (c) 0.1 M 2-mercaptoethanol- 
treated Clf and the isolated heavy (d) and light (e) chains of 
Clf  in 5% polyacrylamide g ls with 0.2% SDS and 0.2 M 
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Fig.3. Inhibition of Clf by DFP. Clf  (about 0.2 mg) in 10 ml 
of 0.1 M Tris-HC1 buffer, pH 8.5 was incubated with 0.25 
mM of DFP at 37°C. ' After the time indicated, 1ml of the 
reaction mixture was withdrawn and the remaining esterase 
activity of Clf  was determined with 5 #tool of AAME as 
substrate. The remaining esterase activity was expressed as
the per cent to the esterase activity of Clf  not treated with 
DFP. 
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Fig.4. SDS-polyacrylamide g l electrophoresis of [s2 p].DFP. 
treated C 1L [ a 2 p]' D FP-treated C1 ]? was electrophoresed in 
5% polyacrylamide gel with 0.2% SDS and 0.2 M phosphate 
buffer, pH 7.3 before (a) and after (b) treatment with 0.1 
M 2-mercaptoethanol. The gels were stained with Coomasie 
blue, sectioned into each 2 mm width and counted for the 
distribution of radioactive [s2 p] DIP as described in Exper- 
imental. 
3.4. The NH2-terminal mino acids of Cff 
The two polypeptide chains of CI~ were isolated 
by analytical scale SDS-polyacrylamide gelelectro- 
phoresis of 2-mercaptoethanol-treated C 1 ~ (fig.2d and 
2e). 
By SDS-dansyl microtechnique [16], isoleucine 
was identified as the NH2-terminal mino acid of both 
heavy and light chains of human CI~. 
4. Discussion 
As mentioned by de Bracco and Stroud [9], the 
extraordinary instability of C 1~ has made its purific- 
ation and structural studies extremely difficult. The 
present purification procedure is reproducible and can 
be done only in four days with a good recovery. 
In a previous paper [9], we reported that human 
CI~ cleaves Cls into heavy and light chains; the heavy 
chain of Clff is derived from the NH~-terminal port- 
ion of the zymogen molecule and tne light chain from 
the COOH-terminal portion. In addition, the four 
NH2-terminal nimo acid sequences of the light chain 
of CI~ was found to be homologous to those of other 
serine proteases in plasma. 
The two chain structure of CI~ appears to be very 
similar to that of Clff; (1) the molecular weight of 
heavy chain of C1~ is the same as that of heavy chain 
of C 1 if, (2) the DFP-sensitive active sites of C 1 ? and 
Clff locate on the light chain portions of each enzyme 
and (3) Ile is the NH2-terminal mino acid of light 
chain of Clr as well as Clg. An apparent difference 
between CI~ and Clff was that the molecular weight 
of light chain of C1 r is larger than that of light chain 
of Clff by about 10 000. 
These structural similarities between CI~ and Clff 
may suggest hat the mechanism of activation of Clr 
is similar to that of Cls; Clr is present as a single 
polypeptide chain and is proteolytically converted 
into active Clr- composed of two chains. 
Recently, Valet and Cooper [20] have reported 
the isolation of C 1 r zymogen from human serum, but 
it still remains to be solved whether Clr zymogen is 
composed of a single polypeptide chain or two poly- 
peptide chains connected by disulfide bridge(s). 
If the activation of Clr is a proteolytic process, as 
proposed in this paper, it is a subject of interest what 
is the activating enzyme for Cir. Recently, it is pro- 
posed that during zymogen activation, a latent enzy- 
matic activity becomes very greatly enhanced rather 
than being generated de novo [21]. In supporting this 
model, McClintock and Bell presented evidence indicat- 
ing that in the case of activation of plasminogen by 
streptokinase, streptokinase first induces a reversible 
conformational exposure of the latent active site in 
plasminogen molecule which may subsequently be 
permanently exposured by a spontaneous peptide 
bond cleavage [22]. 
So, it seems likely that binding of Clq subunit in 
C1 macromolecnle to immune complex induces ome 
conformational change in Clr molecule to recover 
the latent active site of C lr, and the activated state 
of Clr is f'mally stabilized by a spontaneous cleavage 
of X - Ile peptide bond in the zymogen molecule. 
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